Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.
about
Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatmentCompartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementiaMonocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studiesRelationship of Human Immunodeficiency Virus Viral Load in Cerebrospinal Fluid and Plasma in Patients Co-infected With Cryptococcal Meningitis.Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells.Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.Characterization of peripheral blood human immunodeficiency virus isolates from Hispanic women with cognitive impairment.Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research.Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope.Study of compartmentalization in the visna clinical form of small ruminant lentivirus infection in sheep.Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis.Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection.Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis.A machine learning approach for identifying amino acid signatures in the HIV env gene predictive of dementia.HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapiesNeurologic complications of HIV disease and their treatment.Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course.Controversies in HIV-associated neurocognitive disordersThe HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia.Compartmentalization and evolution of feline immunodeficiency virus between the central nervous system and periphery following intracerebroventricular or systemic inoculation.Cerebrospinal fluid is an efficient route for establishing brain infection with feline immunodeficiency virus and transfering infectious virus to the periphery.Compartmentalization, Viral Evolution, and Viral Latency of HIV in the CNS.Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts.Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1.The cerebrospinal fluid proteome in HIV infection: change associated with disease severityEarly Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA PopulationsHigher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approachesDeep sequencing of HIV-1 variants from paired plasma and cerebrospinal fluid during primary HIV infectionGenetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.Feline immunodeficiency virus neuropathogenesis: from cats to calcium.Tissue reservoirs of HIVAntiretroviral therapy and central nervous system HIV type 1 infectionCerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis.Tissue-specific HIV-1 infection: why it matters.HIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads.Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy.Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?
P2860
Q24814874-19C18BE3-76CB-4029-8FB4-552BE00A242CQ28475360-1CA6642D-AE0D-4251-B71F-65510D04C65EQ28751900-06A17A66-C1AE-4452-BDFA-DB4082F51243Q33609454-3BDDA4F0-94DC-4345-BAA3-5CF5C195D749Q33843510-7877B471-7150-4E18-85A9-4849E8626854Q33883813-522BEC35-8853-4829-8CA7-2301ED9BC2E8Q33933507-9470DB13-0BDA-4F1C-9F68-31D1CCCAEFC2Q34077857-3B8E20E6-B1CF-4961-AABB-B0D229E62124Q34080236-54DFBDDA-0515-4BB7-9E7D-34C15B42CE1FQ34091371-3CCE29E8-B71B-4775-B79A-67C774ADC9CAQ34142442-809B5910-AF50-45E5-B3B4-7E37C87303B0Q34170655-5C2C2917-C8CA-47B2-A7EE-519A753A3395Q34173947-C0EBBB29-1D8E-4173-9281-654DD681A45EQ34178242-A7D7CBA0-563F-4A4F-BDE1-260934EA5A95Q34482480-9E7809B5-7F63-47ED-BA10-4848563602ABQ34599414-53149451-50A1-4838-A7F7-E93F9DA23C3AQ34730716-F66283F5-E636-48A8-8B3C-DBA0FD69DCF9Q34803017-A2CCB79C-BEDF-469E-9D04-C182C3918BA7Q34950897-00C245BE-71A2-49E7-AF7B-59B760ADAF7EQ35037015-5BDFB9FC-88DF-4F92-B27E-8D857411BAFDQ35062297-9F056E7D-2055-4A04-8077-7D3D68684B48Q35088127-B9669AB5-709A-4CF7-BF57-5422A46FB710Q35195923-C2D86B5D-4E10-4B92-AA38-40F5F134F006Q35606068-F568AD41-6DFF-48E5-B10E-83D999952FA7Q35815274-2877B195-9260-4877-AB61-5EA2398F556DQ35857191-EA1BA89D-BF2B-499A-809B-57142F7F1EE2Q35965332-3D748D4C-0858-4B38-B858-31F1A9D3C3B9Q36238501-42DAEC09-C546-4C89-9DB5-0AC464CBA628Q36303531-3D9B843D-9C62-451C-9464-373A40D9F4FCQ36530897-4F3969D8-9EB9-443E-8831-9BD6459F6AE4Q36551179-E1724921-8FC3-4908-9FD6-45C0076479BBQ36609063-C568AA52-674D-4729-8B05-0F0D33139214Q37015529-2780A9EC-BE1E-4E7E-BD83-6D362123A260Q37055454-EDF1E8C7-A793-41D1-9AB8-B5CA85AA7132Q37066982-0F50BBAA-247B-439E-B078-3AEDB217BA81Q37084988-F4A5F462-29CE-4B0C-AE38-DC44A6EBA1BAQ37089202-96C05C71-AEC6-48FA-8E30-9C00B893B28EQ37300347-D51CD1D9-6E96-46A5-A08B-B2078247F480Q37354047-A3752033-EC3D-4825-8595-00BC6225102AQ37362071-FA2C6C34-C7E0-4644-A210-B311BA886A5F
P2860
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Genetic composition of human i ...... ailing antiretroviral therapy.
@ast
Genetic composition of human i ...... ailing antiretroviral therapy.
@en
type
label
Genetic composition of human i ...... ailing antiretroviral therapy.
@ast
Genetic composition of human i ...... ailing antiretroviral therapy.
@en
prefLabel
Genetic composition of human i ...... ailing antiretroviral therapy.
@ast
Genetic composition of human i ...... ailing antiretroviral therapy.
@en
P2093
P2860
P50
P1433
P1476
Genetic composition of human i ...... failing antiretroviral therapy
@en
P2093
C C Ignacio
D D Richman
J A McCutchan
J Marquie-Beck
M C Strain
S K Pillai
P2860
P304
P356
10.1128/JVI.79.3.1772-1788.2005
P577
2005-02-01T00:00:00Z